Ground breaking research on cancer stem cells as targets and normal stem cells in Immunotherapy will be discussed at the 2nd Annual Cancer Immunotherapy Conference in Washington DC on April 4-5, 2013.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130131005114&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130131005114&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment